Glenview Trust’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.15M | Buy |
7,076
+156
| +2% | +$69.5K | 0.05% | 187 |
|
|
2025
Q1 | $3.35M | Buy |
6,920
+30
| +0.4% | +$14.5K | 0.07% | 170 |
|
|
2024
Q4 | $2.77M | Buy |
6,890
+152
| +2% | +$61.2K | 0.05% | 184 |
|
|
2024
Q3 | $3.13M | Sell |
6,738
-12
| -0.2% | -$5.58K | 0.06% | 172 |
|
|
2024
Q2 | $3.16M | Buy |
6,750
+180
| +3% | +$84.4K | 0.06% | 166 |
|
|
2024
Q1 | $2.75M | Buy |
6,570
+180
| +3% | +$75.2K | 0.06% | 176 |
|
|
2023
Q4 | $2.6M | Buy |
6,390
+98
| +2% | +$39.9K | 0.06% | 173 |
|
|
2023
Q3 | $2.19M | Hold |
6,292
| – | – | 0.06% | 173 |
|
|
2023
Q2 | $2.21M | Buy |
6,292
+57
| +0.9% | +$20.1K | 0.06% | 170 |
|
|
2023
Q1 | $1.96M | Sell |
6,235
-155
| -2% | -$48.8K | 0.06% | 175 |
|
|
2022
Q4 | $1.85M | Buy |
6,390
+527
| +9% | +$152K | 0.06% | 170 |
|
|
2022
Q3 | $1.7M | Buy |
5,863
+684
| +13% | +$198K | 0.06% | 161 |
|
|
2022
Q2 | $1.46M | Buy |
5,179
+24
| +0.5% | +$6.76K | 0.05% | 170 |
|
|
2022
Q1 | $1.35M | Buy |
+5,155
| New | +$1.35M | 0.04% | 186 |
|
|
2021
Q4 | – | Sell |
-3,890
| Closed | -$705K | – | 431 |
|
|
2021
Q3 | $705K | Buy |
3,890
+1,915
| +97% | +$347K | 0.03% | 229 |
|
|
2021
Q2 | $398K | Buy |
+1,975
| New | +$398K | 0.02% | 305 |
|